Category Specific RSS

News

Could Dimerix be first to market with their innovative kidney disease drug?

Clinical-stage biopharmaceutical company Dimerix (ASX: DXB) has today announced that their current Phase 3 drug for kidney disease has been…

5 years ago

Casino industry in disarray as SkyCity joins list of money-laundering investigations

As an industry which has long been a vital gateway for organised crime, financial crime regulators appear to finally be…

5 years ago

Openn Negotiation proptech IPO to bring transparency to real estate market

The slimy sales tactics of prickly real estate agents may be in need of review with Australian property technology company…

5 years ago

Stealth secures major customer boost via $4.2m acquisition of Skipper Transport Parts

Industrial and automotive supplies company Stealth Global Holdings (ASX: SGI) has secured some of Australia’s largest companies as new clients…

5 years ago

Smart pain assessment app now used by more than half of Australia’s residential aged care providers

Intelligent pain assessment company Painchek (ASX: PCK) is eager to become the new standard of care in aged care settings,…

5 years ago

PharmAust receives ethics approval just in time for Big Freeze

There is nothing fun about plunging into freezing cold ice water during a cold Melbourne winter. However, each year, bold…

5 years ago

‘Working from home’ here to stay as productive Australians focus on wellbeing

Among the many unknowns to emerge from the pandemic, the working from home phenomenon has plagued executive management but questions…

5 years ago

Genetic Technologies launches AI-based COVID Risk Test

Personalised medicine is quickly becoming the new standard of healthcare thanks to the ease of genetic testing and technological advancements.…

5 years ago

Adherium submits FDA application for smart inhaler to digitise respiratory treatment

Sufferers of asthma and COPD in the United States could soon have access to a digital inhaler device that will…

5 years ago

Nuix confirms profit downgrade as shares keep tumbling with class action pending

Embattled forensic software and data analytics company Nuix (ASX: NXL) is deep in damage control following media reports of questionable…

5 years ago